Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses

The emergent human coronavirus SARS-CoV-2 and its high infectivity rate has highlighted the strong need for new disinfection systems. Evidence has proven that airborne transmission is an important route of spreading for this virus. Therefore, this short communication introduces CLODOS Technology(®),...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreu, Sabina, Ripa, Inés, Bello-Morales, Raquel, López-Guerrero, José Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005127/
https://www.ncbi.nlm.nih.gov/pubmed/33807081
http://dx.doi.org/10.3390/v13030531
_version_ 1783672062497259520
author Andreu, Sabina
Ripa, Inés
Bello-Morales, Raquel
López-Guerrero, José Antonio
author_facet Andreu, Sabina
Ripa, Inés
Bello-Morales, Raquel
López-Guerrero, José Antonio
author_sort Andreu, Sabina
collection PubMed
description The emergent human coronavirus SARS-CoV-2 and its high infectivity rate has highlighted the strong need for new disinfection systems. Evidence has proven that airborne transmission is an important route of spreading for this virus. Therefore, this short communication introduces CLODOS Technology(®), a novel strategy to disinfect contaminated surfaces. It is a product based on stable and 99% pure chlorine dioxide, already certified as a bactericide, fungicide and virucide against different pathogens. In this study, CLODOS Technology(®), by direct contact or thermonebulization, showed virucidal activity against the human coronavirus HCoV-229E at non-cytotoxic doses. Different conditions such as nebulization, exposure time and product concentration have been tested to standardize and optimize this new feasible method for disinfection.
format Online
Article
Text
id pubmed-8005127
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80051272021-03-29 Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses Andreu, Sabina Ripa, Inés Bello-Morales, Raquel López-Guerrero, José Antonio Viruses Communication The emergent human coronavirus SARS-CoV-2 and its high infectivity rate has highlighted the strong need for new disinfection systems. Evidence has proven that airborne transmission is an important route of spreading for this virus. Therefore, this short communication introduces CLODOS Technology(®), a novel strategy to disinfect contaminated surfaces. It is a product based on stable and 99% pure chlorine dioxide, already certified as a bactericide, fungicide and virucide against different pathogens. In this study, CLODOS Technology(®), by direct contact or thermonebulization, showed virucidal activity against the human coronavirus HCoV-229E at non-cytotoxic doses. Different conditions such as nebulization, exposure time and product concentration have been tested to standardize and optimize this new feasible method for disinfection. MDPI 2021-03-23 /pmc/articles/PMC8005127/ /pubmed/33807081 http://dx.doi.org/10.3390/v13030531 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Communication
Andreu, Sabina
Ripa, Inés
Bello-Morales, Raquel
López-Guerrero, José Antonio
Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_full Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_fullStr Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_full_unstemmed Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_short Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_sort nebulized clodos technology shows clear virucidal properties against the human coronavirus hcov-229e at non-cytotoxic doses
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005127/
https://www.ncbi.nlm.nih.gov/pubmed/33807081
http://dx.doi.org/10.3390/v13030531
work_keys_str_mv AT andreusabina nebulizedclodostechnologyshowsclearvirucidalpropertiesagainstthehumancoronavirushcov229eatnoncytotoxicdoses
AT ripaines nebulizedclodostechnologyshowsclearvirucidalpropertiesagainstthehumancoronavirushcov229eatnoncytotoxicdoses
AT bellomoralesraquel nebulizedclodostechnologyshowsclearvirucidalpropertiesagainstthehumancoronavirushcov229eatnoncytotoxicdoses
AT lopezguerrerojoseantonio nebulizedclodostechnologyshowsclearvirucidalpropertiesagainstthehumancoronavirushcov229eatnoncytotoxicdoses

Ejemplares similares